Xiaowu Y. Li

No. 1098, Xue Yuan Avenue
Shenzhen, 518055, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Entropy-mediated ultrafine PdSnPtAgBi nanoparticles as a high-performance electrocatalyst with enhanced CO tolerance for alcohol oxidation.

Entropy-mediated ultrafine PdSnPtAgBi nanoparticles as a high-performance electrocatalyst with enhanced CO tolerance for alcohol oxidation.

Journal: Journal of colloid and interface science

Published: September 30, 2025

Retraction: CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.

Retraction: CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.

Journal: Nanoscale advances

Published: September 24, 2025

Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study.

Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study.

Journal: The Lancet. Oncology

Published: April 29, 2025

Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplantation tumor model induced by PANC-1/ADR human pancreatic cancer resistant strain cells.

Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplantation tumor model induced by PANC-1/ADR human pancreatic cancer resistant strain cells.

Journal: Nanotheranostics

Published: December 23, 2024

Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine.

Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine.

Journal: Clinical chemistry and laboratory medicine

Published: February 07, 2024

CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy.

CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy.

Journal: Experimental hematology & oncology

Published: December 15, 2023

Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.

Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.

Journal: The oncologist

Published: October 08, 2022

Correction: CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.

Correction: CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.

Journal: Nanoscale advances

Published: September 14, 2022

NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC).

NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC).

Journal: ACS pharmacology & translational science

Published: August 11, 2022

DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.

DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.

Journal: International journal of nanomedicine

Published: April 14, 2022

Neoadjuvant Therapy for Hepatocellular Carcinoma.

Neoadjuvant Therapy for Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: January 09, 2022

Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma.

Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma.

Journal: Frontiers in oncology

Published: December 01, 2021

Showing 1-12 of 53

Last Updated: 09/26/2026